No, Xarelto (rivaroxaban) does NOT need to be stopped prior to cataract surgery.
Cataract surgery can be safely performed while continuing rivaroxaban without interruption, provided topical or intracameral anesthesia is used rather than needle-based regional blocks.
Evidence-Based Rationale
The 2022 American College of Chest Physicians guideline specifically addresses this scenario. A 25-patient observational study of patients undergoing cataract surgery while continuing DOAC therapy (including rivaroxaban) identified zero bleeding events 1. This supports continuation of anticoagulation for this low-bleeding-risk procedure.
Key Clinical Considerations
Anesthesia Selection is Critical
- Use topical or intracameral anesthesia exclusively - this is the safest approach
- Avoid peribulbar or retrobulbar needle injections - these carry substantially higher bleeding risk with anticoagulation
- The 2022 Ophthalmology cataract guideline emphasizes appropriate anesthesia selection as part of surgical planning 2
Supporting Evidence for Continuation
Multiple studies demonstrate safety:
- A 2019 prospective case series of 35 eyes in patients on NOACs (including rivaroxaban) showed 85% were at therapeutic anticoagulation levels during surgery, with only minor conjunctival/limbal bleeding in 5 eyes and no intraocular hemorrhage 3
- A 2019 New Zealand audit found no statistically significant increase in hemorrhagic complications with anticoagulation, and complications that did occur were minor and not visually significant 4
The Risk-Benefit Analysis
Stopping rivaroxaban poses greater danger than continuing it:
- Discontinuing anticoagulation increases thromboembolic risk (stroke, MI, PE)
- Cataract surgery is classified as a low-bleeding-risk procedure when performed with appropriate technique
- The 2022 CHEST guideline framework categorizes procedures by bleeding risk, and low-risk procedures generally do not require interruption 1
Common Pitfalls to Avoid
- Do not reflexively stop anticoagulation - this outdated practice increases life-threatening thromboembolic events
- Do not use needle-based regional anesthesia - this converts a low-risk procedure into a high-risk one
- Do not confuse cataract surgery with other intraocular procedures - more invasive surgeries may require different management
Practical Algorithm
For patients on rivaroxaban scheduled for routine cataract surgery:
- Continue rivaroxaban at usual dose
- Plan topical or intracameral anesthesia only
- Proceed with standard phacoemulsification technique
- No bridging therapy needed
- No laboratory monitoring required
The only exception: If complex cataract surgery is anticipated with high likelihood of complications, or if the surgeon insists on needle-based anesthesia, then discuss with the prescribing physician about temporary interruption using the CHEST guideline framework for low-moderate bleeding risk procedures (1 day before, 1 day after) 1.